Brooklyn Immuno Therapeutics acquires IRX Therapeutics’ assets for cytokine-based cancer therapy
Brooklyn Immuno Therapeutics, a New York-based clinical-stage biopharmaceutical company specializing in cytokine-based cancer therapies, has announced the acquisition of IRX Therapeutics’ assets. The terms of the deal were not disclosed. Brooklyn Immuno Therapeutics, a company focused on developing innovative treatments for cancer, has expanded its portfolio by acquiring IRX Therapeutics. This acquisition positions Brooklyn Immuno […]